Company Seeks To Enjoin FDA From Restricting Speech About Off-Label Uses

(September 30, 2015, 10:49 AM EDT) -- NEW YORK — On the heels of a ruling in a similar case, Pacira Pharmaceuticals Inc. on Sept. 8 filed a declaratory action seeking to enjoin the Food and Drug Administration from prohibiting the company from making truthful and nonmisleading speech about off-label uses for one of its products (Pacira Pharmaceuticals, Inc., et al. v. United States Food & Drug Administration, et al., No. 15-7055, S.D. N.Y.).

(Pacira complaint available. Document #28-151001-016C.)

Pacira makes and markets Exparel, a combination of the local anesthetic bupivacaine and DepoFoam....
To view the full article, register now.